Jump to content

Category:Ioana I. Nitulescu of San Diego CA (US)

From WikiTrademarks

Ioana I. Nitulescu of San Diego CA (US)

Executive Summary

Ioana I. Nitulescu of San Diego CA (US) is an inventor who has filed 1 patents. Their primary areas of innovation include the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds (1 patents), SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS (1 patents), Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] (1 patents), and they have worked with companies such as Salk Institute for Biological Studies (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Ioana I. Nitulescu of San Diego CA (US) Monthly Patent Applications.png

Technology Areas

File:Ioana I. Nitulescu of San Diego CA (US) Top Technology Areas.png

List of Technology Areas

  • A61K47/55 (the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds): 1 patents
  • A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P29/00 (Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]): 1 patents
  • A61P31/14 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents

Companies

File:Ioana I. Nitulescu of San Diego CA (US) Top Companies.png

List of Companies

  • Salk Institute for Biological Studies: 1 patents

Collaborators

Subcategories

This category has the following 3 subcategories, out of 3 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.